APFP
NVAX icon

Action Point Financial Planning’s Novavax NVAX Stock Holding History

Action Point Financial Planning’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188 Buy
+20
New +$179 ﹤0.01% 2703

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Action Point Financial Planning's NVAX Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Novavax (NVAX) in Q2 2026: 20 shares worth $188. The stake represents ﹤0.01% of the portfolio and ranks #2703 among its holdings.

264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Action Point Financial Planning held 20 shares of Novavax worth $188 as of Q2 2026.
  • Novavax was a new Action Point Financial Planning position in Q2 2026.
  • Novavax made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #2703 holding.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.